Initial findings of the AASK: African Americans with hypertensive kidney disease benefit from an ACE inhibitor.
Experts have long thought that African Americans were less responsive to ACE inhibitors than other racial or ethnic groups. The African American Study of Kidney Disease and Hypertension (AASK) provides the first evidence of a beneficial effect of ACE inhibition on renal function in African American patients, in addition to excellent blood pressure control.
Rahman
Mahboob
M
Division of Hypertension, Case Western Reserve University, University Hospitals of Cleveland, OH 44106, USA. mxr9@po.cwru.edu
D001741:Black or African American; D017311:Amlodipine / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000208:ethnology*; D008297:Male; D008875:Middle Aged; D017257:Ramipril / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D017311:Amlodipine; D017257:Ramipril